Company intelligence / Profile preview

Discoverybytes

Oregon, United Statesdiscoverybytes.com ↗

Ownership: Private
Development stage: Commercial

Overview

Discovery Biotech focuses on overcoming cancer therapy resistance by translating scientific discoveries into novel drug candidates. They are at the forefront of Cancer Treatment Resistance Therapy (CTRT), aiming to address unmet needs in oncology by developing solutions for patients who do not respond to standard treatments. No specific clinical results are disclosed publicly yet.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

nevirapine

Commercial

Indications: HIV

Beyond the preview

Go deeper on Discoverybytes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Discoverybytes.

Explore the full profile